Sujatha Gurunathan

Clinical Trial Alert with image of researcher's gloved hand holding a test tube
Blog Post

Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults with Generalized Myasthenia Gravis (gMG)

By Sujatha Gurunathan | March 9, 2023
Blog Post

FDA Approves Reata’s SKYCLARYS for Treatment of FA

By Sujatha Gurunathan | February 28, 2023
3d rendered image shown neuromuscular junction, where nerve end splits into several neural end plates on different muscle cells.
Blog Post

Simply Stated: Research Updates in Facioscapulohumeral Muscular Dystrophy (FSHD)

By Sujatha Gurunathan | February 28, 2023
Blog Post

Clinical Trial Alert: Phase 2 Study of EDG-5506 in Adults or Adolescents with BMD

By Sujatha Gurunathan | February 1, 2023
Scientist examines DNA models on a lab screen
Blog Post

Simply Stated: Updates in Oculopharyngeal Muscular Dystrophy (OPMD)

By Sujatha Gurunathan | January 26, 2023
Graphic of DNA double helix on top of scientist with gloved hand holding a test tube
Blog Post

Perspectives on Gene Therapy Products for Neuromuscular Disease

By Sujatha Gurunathan | December 19, 2022
Research Study Alert with image of researcher writing on clipboard
Blog Post

Research Study Alert: Survey Examining Transfers of Care in the SMA Community

By Sujatha Gurunathan | December 14, 2022
Clinical Trial Alert with image of researcher's gloved hand holding a test tube
Blog Post

Clinical Trial Alert: Medical Device Feasibility Study for People with Paralysis

By Sujatha Gurunathan | December 14, 2022
Clinical Trial Alert with image of medical researcher looking at computer screen
Blog Post

Clinical Trial Alert: Phase 2 Study of a New Tool for Muscle Assessment in People with Neuromuscular Disease

By Sujatha Gurunathan | December 14, 2022
Blog Post

Research Study Alert: Survey Examining Urinary and Gastrointestinal Symptoms Associated with SMA

By Sujatha Gurunathan | November 21, 2022